(Q30772153)

26 June 2017

1 reference

title

A critical discussion of the role of neuroimaging in mild cognitive impairment (English)

1 reference

mild cognitive impairment

26 June 2017

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

6

Lars-Olof Wahlund

0 references

Agneta Nordberg

4

object named as

Agneta Nordberg

1 reference

26 June 2017

Henrike Wolf

1

1 reference

26 June 2017

Vesna Jelic

2

1 reference

26 June 2017

Hermann-Josef Gertz

3

1 reference

26 June 2017

Per Julin

5

1 reference

26 June 2017

1 January 2003

1 reference

Acta neurologica Scandinavica. Supplementum

26 June 2017

1 reference

26 June 2017

179

1 reference

26 June 2017

52-76

1 reference

SENESCENT MEMORY IMPAIRMENT AND ITS RELATION TO THE GENERAL HEALTH OF THE AGING INDIVIDUAL

26 June 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

1 reference

7 January 2021

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

The prognosis of mild cognitive impairment in the elderly.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Independent predictors of cognitive decline in healthy elderly persons.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MRI of amygdala fails to diagnose early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Cognitive decline in AD and mild cognitive impairment is associated with global brain damage.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Regional magnetization transfer ratio changes in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Evidence for atrophy of the corpus callosum in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Morphometry of the corpus callosum in patients with questionable and mild dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression--a longitudinal evaluation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Positron emission tomography in familial Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Presenilin-1-associated abnormalities in regional cerebral perfusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Preclinical prediction of Alzheimer's disease using SPECT.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal perfusion in mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Posterior cingulate cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hypofunction in the posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Characteristics of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Three-dimensional texture analysis of MRI brain datasets.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MR image-based measurement of rates of change in volumes of brain structures. Part I: method and validation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Rates of global and regional cerebral atrophy in AD and frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Hippocampal volume losses in minimally impaired elderly.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Preclinical prediction of AD using neuropsychological tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

A New Systematic Method of Measurement and Diagnosis of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-III-R Criteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.107.S179.10.X

7 January 2021

10.1034/J.1600-0404.107.S179.10.X

Identifiers

DOI

0 references

1 reference